PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre de Recherche du CHUM, Montréal, QC H2X 0A9, Canada.\', \'Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.\', \'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA 98109, USA.\', \'Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD 20892, USA.\', \'Department of Global Health, University of Washington, Seattle, WA 98195, USA.\', \'Héma-Québec, Affaires Médicales et Innovation, Québec, QC G1V 5C3, Canada.\', \'Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • E121410.3390/v12111214
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 33114742
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all